Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-04-03Clinical Trial Update: Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study
An observational study evaluating hepatitis C infection in chronic hemodialysis patients. The status of the trial is currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection [Phase 1]
Phase 1 trial update evaluating sofosbuvir-containing regimens without interferon for acute hepatitis C infection, including participants wi…
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy [NA]
A completed pilot clinical trial evaluating directly observed anti-Hepatitis C therapy with contingency management in people on opiate subst…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection [Phase 3]
This Phase 3 study evaluating daclatasvir and sofosbuvir with ribavirin in patients with cirrhosis and genotype 3 hepatitis C has completed,…
-
CLINICAL_TRIALS research · 2018-03-23Clinical Trial Update: Pathology of Hepatitis c Nephropathy
An update on a clinical trial examining the pathology of cryoglobulinaemia-associated nephropathy in chronic hepatitis C.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
A prospective cohort trial evaluating Hepatitis C screening strategies — CDC birth-cohort recommendations versus traditional risk-factor-bas…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) [Phase 2]
This phase 2 trial evaluated a fixed-dose combination of grazoprevir, uprifosbuvir, and ruzasvir in chronic hepatitis C patients who failed …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients [Phase 4]
A Phase 4 trial update reports on sofosbuvir-containing regimens for chronic hepatitis C infection, genotype 2.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients [Phase 3]
Phase 3 trial evaluating sofosbuvir-containing regimens for chronic hepatitis C virus infection genotype 3 has completed enrollment and stat…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients [Phase 2, Phase 3]
Completed Phase 2 and Phase 3 clinical trials evaluating the combination of sofosbuvir and daclatasvir in Chinese patients with treatment-ex…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection [Phase 3]
A Phase 3 trial evaluated a fixed-dose combination of ledipasvir/sofosbuvir given for 12 weeks in adults with chronic genotype 2 HCV infecti…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy [Phase 3]
A Phase 3 trial evaluating boceprevir-based therapy to rescue patients with chronic hepatitis C genotype 1 coinfected with hepatitis B who a…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of Yimitasvir in healthy adult subjects has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C [NA]
Completed trial evaluating safety and efficacy of generic sofosbuvir with ribavirin for treatment-naive genotype 2 chronic hepatitis C.
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis
A clinical trial update evaluating MRI apparent diffusion coefficient (ADC) values as a non-invasive method to assess liver cirrhosis in pat…
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C
This clinical trial update documents the completed observational study evaluating Pegasys in dual- or triple-therapy regimens for chronic he…
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 [Phase 2]
Phase 2 trial evaluating E5501 for hepatitis C virus–related thrombocytopenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection [Phase 3]
Phase 3 trial update on sofobuvir plus ribavirin in adults with chronic hepatitis C shows efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF [Phase 2]
Phase 2 trial comparing 12 weeks of ledipasvir/sofosbuvir with weight-based ribavirin to 24 weeks of ledipasvir/sofosbuvir in patients with …
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection [Phase 3]
A Phase 3 trial assessing safety and efficacy of the fixed-dose combination ledipasvir/sofosbuvir in adults with chronic hepatitis C and hep…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II [Phase 2]
Phase 2 study evaluating the efficacy and safety of a 12-week triple therapy consisting of danoprevir/ritonavir plus pegylated interferon al…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C [Phase 2]
Phase 2 trial update evaluating safety and efficacy of KW-136 with Sofosbuvir for chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients [Phase 2]
Phase 2 trial update describing efficacy and safety of Qurevo Plus Ribavirin therapy for chronic hepatitis C in haemodialysis patients, with…
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study [Phase 3]
A Phase 3 follow-up trial investigating viral activity in chronic hepatitis C patients who previously failed feeder DEB025/Alisporivir; the …
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Ribavirin, Its Dosing Regime [Phase 4]
A Phase 4 clinical trial update on ribavirin dosing regime for Hepatitis C has completed.